300238.SZ
冠昊生物
SZSE · Healthcare · C 制造业 · CN
CNY 11.44
−4.27%Margins
Gross margin
77.0%
EBITDA margin
13.5%
EBIT margin
6.0%
Net margin
5.1%
FCF margin
4.3%
3.4%
Return on equity
2.5%
Return on assets
3.3%
Return on invested capital
0.48x
Asset turnover
CNY 42.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026